Journal Papers,
Abstracts, and Commentaries
| |
Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding
while on nevirapine prophylaxis: results of the Breastfeeding, Antiretrovirals
and Nutrition study.
Nelson JA, Fokar A, Hudgens MG, et al
AIDS. 2015 Jul 17.
Abstract
Breast milk transmission of nevirapine-resistant HIV-1 to infants after
single-dose nevirapine in Beira, Mozambique.
Micek MA, Dross S, Blanco AJ, et al
J Infect Dis. 2014 Mar 4
Abstract
Effects of short-course zidovudine on the selection of
nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
Micek MA, Blanco AJ, Carlsson J, et al
J Infect Dis.
2012 Apr 5.
Abstract
A Comparison of 3 Regimens to Prevent Nevirapine Resistance
Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of
Nevirapine.
Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, et
al
Clin Infect Dis. 2011 Dec 5.
Abstract
FULL-TEXT ARTICLE
Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan
Women after Nevirapine Single-Dose Prophylaxis.
Hauser A, Mugenyi K, Kabasinguzi R, et al
PLoS One. 2011;6(5):e20357.
Paper
FULL-TEXT ARTICLE
Detection of HIV drug resistance mutations in pregnant women receiving
single dose
Nevirapine in south India.
Jacob MS, Durairaj A, Vijayakumari J,
et al
Indian J Pathol Microbiol. 2011
April-June;54(2):359-361.
Paper
Analysis of nevirapine resistance in HIV-infected infants who received extended
nevirapine or
nevirapine/zidovudine prophylaxis.
Fogel J, Hoover DR, Sun J,
et al
AIDS. 2011 Apr
24;25(7):911-917.
Abstract
Minor drug-resistant HIV type-1 variants in breast milk and
plasma of HIV type-1-infected Ugandan women
after nevirapine single-dose prophylaxis.
Pilger D, Hauser A, Kuecherer C, Mugenyi K, et al
Antivir Ther.
2011;16(1):109-13.
Abstract
Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended
Nevirapine Prophylaxis
for Prevention of Mother-to Child HIV-Transmission.
Persaud D, Bedri A, Ziemniak C,
et al
AIDS Res Hum Retroviruses.
2011 Jan 18.
Abstract |
Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose
nevirapine effectively
reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi.
Farr SL, Nelson JA, Ng'ombe TJ,, et al
J Acquir Immune Defic Syndr. 2010
Aug 15;54(5):515-23
Abstract |
FULL-TEXT ARTICLE
Minor resistant variants in nevirapine-exposed infants may
predict virologic failure
on nevirapine-containing ART.
Macleod IJ, Rowley CF, Thior I, Wester
C, et al
J Clin Virol. 2010 Apr
26.
Abstract |
Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants
Treated with
Single-Dose Nevirapine.
Micek MA, Blanco AJ, Beck IA,
et al
Clin Infect Dis.
2010 Apr 12
Abstract |
Detection of HIV-1-Drug-Resistance in Women Following Single-Dose-Nevirapine:
Comparison of Plasma RNA versus Cellular DNA by Consensus Sequencing and by
Oligonucleotide Ligation Assay.
Wagner TA, Kress CM, Beck I, et al
J Clin Microbiol.
2010 Feb 24
Abstract |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces
nevirapine
resistance in infants who were HIV-infected in utero.
Lidström J, Li Q, Hoover DR, Kafulafula G,
et al
AIDS.
2010 Jan 28;24(3):381-6.
Abstract |
Tolerance and viral resistance after single-dose nevirapine with
tenofovir and emtricitabine to prevent
vertical transmission of HIV-1.
The TEmAA ANRS 12109 Study group.
AIDS. 2009
Mar 19.
Abstract |
Addition of extended zidovudine to extended nevirapine prophylaxis reduces
nevirapine resistance
in infants who were HIV-infected in utero.
Lidström J, Li Q, Hoover DR, et al
AIDS.
2009 Dec 5.
Abstract |
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving
pregnancy-limited
antiretroviral therapy.
Paredes R, Cheng I, Kuritzkes DR, et
al
AIDS.2009
Nov 12
Abstract |
FULL TEXT
ARTICLE
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the
prevention of mother-to-child
HIV transmission: a randomized clinical trial.
McIntyre JA, Hopley M, Moodley D, et al
PLoS
Med. 2009 Oct;6(10):e1000172.
Paper |
Lower Risk of Resistance After Short-Course HAART Compared With
Zidovudine/Single-Dose Nevirapine
Used for Prevention of HIV-1 Mother-to-Child Transmission.
Lehman DA, Chung MH, Mabuka JM, et al
J Acquir Immune Defic Syndr.
2009 Jun 4
Abstract |
Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir
after Single-Dose Nevirapine
to Prevent Mother-to-Child Transmission of HIV-1.
Wind-Rotolo M, Durand C, Cranmer L, et al
J Infect Dis. 2009 Apr 1.
Abstract
|
Development of resistance mutations in women receiving standard
antiretroviral therapy
who received intrapartum nevirapine to prevent perinatal human
immunodeficiency virus
type
1
transmission: a substudy of pediatric AIDS clinical trials group
protocol 316.
Cunningham CK,
Chaix ML, Rekacewicz C, et al
J Infect Dis 2002 Jul 15;186(2):181-8
Abstract
Identification of the K103N resistance mutation in Ugandan women
receiving nevirapine to
prevent HIV-1 vertical transmission.
Jackson JB, Becker-Pergola G, Guay LA, et
al
AIDS 2000 Jul
28;14(11):F111-5
Abstract
Pharmacological
implications of lengthened in-utero exposure to nevirapine.
Taylor GP, Lyall EG, Back D, Ward C,
Tudor-Williams G.
Lancet 2000
Jun 17;355(9221):2134-5
Abstract
|
|
Journal Papers, Abstracts,
and Commentaries
|
Perinatal
NVP Main Page
Main
New/Newsworthy
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
